Literature DB >> 24945694

Cycling-related crash risk and the role of cannabis and alcohol: a case-crossover study.

Mark Asbridge1, Robert Mann2, Michael D Cusimano3, John M Tallon4, Chris Pauley4, Jürgen Rehm5.   

Abstract

OBJECTIVE: To examine whether alcohol and cannabis consumption increase crash risk among non-fatally injured bicyclists (N=393) seen in three Canadian emergency departments, between April 2009 and July 2011.
METHOD: Employing a case-crossover design, cannabis and alcohol were identified through blood sample or by self-report. All cyclists involved in a crash and exposure status (cannabis and alcohol) were compared between case period (current crash) and two control periods: prior to the last time the victim cycled around the same time of day; and the typical use prior to bicycling. Crash risk was assessed through conditional fixed effects logistic regression models.
RESULTS: Approximately 15% of cyclists reported using cannabis just prior to the crash, and 14.5% reported using alcohol. Cannabis use identified by blood testing or self-report in the case period and by self-report in the control period yielded a crash risk of 2.38 (1.04-5.43); however, when self-report was used for both the case and control periods the estimate was 0.40 (0.12-1.27). Alcohol use, as measure either in blood or self-report, was associated with an odds ratio of 4.00 (95% CI: 1.64-9.78); results were similar when alcohol was measured by self-report only.
CONCLUSION: Cannabis and alcohol use each appear to increase the risk of a non-fatal injury-related crash among bicyclists, and point to the need for improved efforts to deter substance use prior to cycling, with the help of regulation, increased education, and greater public awareness. However, cannabis results should be interpreted with caution, as the observed association with crash risk was contingent on how consumption was measured.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcohol; Bicycles; Cannabis; Case-crossover; Crash risk; Injury

Mesh:

Year:  2014        PMID: 24945694     DOI: 10.1016/j.ypmed.2014.06.006

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  6 in total

1.  Crude estimates of cannabis-attributable mortality and morbidity in Canada-implications for public health focused intervention priorities.

Authors:  Benedikt Fischer; Sameer Imtiaz; Katherine Rudzinski; Jürgen Rehm
Journal:  J Public Health (Oxf)       Date:  2015-01-28       Impact factor: 2.341

2.  Traumatic pedestrian and bicyclist injuries associated with intoxication.

Authors:  D J Tonellato; J R Ransohoff; C Nash; S E F Melanson; A K Petrides; N V Tolan; S A Goldberg; E W Boyer; P R Chai; T B Erickson
Journal:  Am J Emerg Med       Date:  2020-08-16       Impact factor: 2.469

3.  Alcohol use by urban bicyclists is associated with more severe injury, greater hospital resource use, and higher mortality.

Authors:  Monica Sethi; Jessica H Heyer; Stephen Wall; Charles DiMaggio; Matthew Shinseki; Dekeya Slaughter; Spiros G Frangos
Journal:  Alcohol       Date:  2016-04-09       Impact factor: 2.405

4.  Motor Vehicle Crashes Involving a Bicycle Before and After Introduction of a Bike Share Program in Philadelphia, Pennsylvania, 2010-2018.

Authors:  Ghassan B Hamra; Leah H Schinasi; D Alex Quistberg
Journal:  Am J Public Health       Date:  2020-04-16       Impact factor: 11.561

5.  Emergency department outpatient treatment of alcohol-intoxicated bicyclists increases the cost of medical care in Japan.

Authors:  Yosuke Homma; Sunao Yamauchi; Michiko Mizobe; Yoshiyuki Nakashima; Jin Takahashi; Hiraku Funakoshi; Kevin Y Urayama; Sachiko Ohde; Osamu Takahashi; Takashi Shiga
Journal:  PLoS One       Date:  2017-03-22       Impact factor: 3.240

6.  Risk Factors for Road-Traffic Injuries Associated with E-Bike: Case-Control and Case-Crossover Study.

Authors:  Zhaohao Zhong; Zeting Lin; Liping Li; Xinjia Wang
Journal:  Int J Environ Res Public Health       Date:  2022-04-24       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.